Cytomegalovirus Infection in Kidney Transplant Recipients
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection in Kidney Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection [Phase 3]
A Phase 3 clinical trial evaluating prophylactic use of Letermovir to prevent CMV infection in kidney transplant recipients at risk for CMV.